Abu Dhabi

The Board of Directors of the Emirates Drug Establishment (EDE) held its fourth meeting since its establishment at the end of last year, to review and develop the main initiatives to be taken for the regulation and management of the UAE’s healthcare and pharmaceutical sectors – all of which are designed to reinforce the UAE’s reputation as a global and regional hub for the medical industry.

The meeting was chaired by  Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade and Chairman of the Board of Directors of the EDE, and was attended by Maha Tayseer, Deputy Chairperson of the Board,  Fatima Mohammed Hilal Al Kaabi, Director General of the EDE, as well as board members  Issa Abdul Fattah Kazim, Badr Saleem Al Ulama, Amer Ahmed Sharif, Farhan Malak, and Professor Chris Evans. Ahmed Al Rumaithi has recently joined the Board as a representative of the UAE’s youth.

During the meeting, the Board of Directors discussed the development of plans for the establishment of various specialized committees to enhance the EDE’s operational efficiency.

The attendees also reviewed the latest developments regarding plans to integrate the activities of all relevant government agencies and services, including the transfer of supervision of more than 160 services from the Ministry of Health and Community Prevention and the Ministry of Climate Change and Environment to the EDE.